Enhanced activity of members of the MAPK family, p38 MAPK and ERK1/2 as well as Akt (the downstream target of PI3K), which we observed in colonic sections post DSS treatment (Figs 8–10) has previously been reported in colonic biopsies from IBD patients [44–47]. The gene discussed is MAPK3; the disease is inflammatory bowel disease.